Auto-inflammatory syndromes and oral health

Oral Diseases

Volumn 14, Issue 8, 2008, Pages 690-699

  Scully, C ^a   Hodgson, T ^a   Lachmann, H ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Amyloid; Aphthae; Auto inflammatory; Fever; Oral; Osteomyelitis, periodic syndrome; Periodic; Ulceration; Ulcers

Indexed keywords

ADALIMUMAB; ANTIINFECTIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; C REACTIVE PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CIMETIDINE; COLCHICINE; CORTICOSTEROID; ETANERCEPT; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; PYRINDAMYCIN A; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SIMVASTATIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN;

AMYLOIDOSIS; APHTHOUS STOMATITIS; AUTOINFLAMMATORY DISEASE; BEHCET DISEASE; BINDING AFFINITY; BLAU SYNDROME; CHRONIC OSTEOMYELITIS; CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS; CINCA SYNDROME; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYROPYRIN ASSOCIATED PERIODIC SYNDROME; DISEASE ASSOCIATION; FAMILIAL COLD AUTOINFLAMMATORY SYNDROME; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; HEALTH; HUMAN; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; INNATE IMMUNITY; MUCKLE WELLS SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPA SYNDROME; PFAPA SYNDROME; PHAGOCYTE; PRIORITY JOURNAL; REVIEW; TONSILLECTOMY; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; UNSPECIFIED SIDE EFFECT;

ACUTE-PHASE REACTION; AUTOIMMUNE DISEASES; BEHCET SYNDROME; FAMILIAL MEDITERRANEAN FEVER; HUMANS; IMMUNITY, INNATE; INFLAMMATION; LYMPHADENITIS; MOUTH DISEASES; OSTEOMYELITIS; PHARYNGITIS; STOMATITIS, APHTHOUS; SYNDROME;

EID: 54049139228     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2008.01484.x     Document Type: Review

References (73)

1. Abril JC, Ramirez A (2007). Successful treatment of chronic recurrent multifocal osteomyelitis with indomethacin: a preliminary report of five cases. J Pediatr Orthop 27 : 587 591.
2. Aganna E, Zeharia A, Hitman GA et al (2002). An Israeli Arab patient with a de novo TNFRSF1A mutation causing tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 46 : 245 249.
3. Aggarwal BB (1992). Tumor necrosis factor. In : Aggarwal BB, Gutterman JU, eds Human cytokines. Blackwell Scientific Publications : Boston, MA, pp. 653 662.
4. Aksentijevich I, Galon J, Soares M et al (2001). The tumor-necrosis- factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet 69 : 301 314.
5. Atagunduz P, Ergun T, Direskeneli H (2003). MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol 21 (Suppl. 30 S35 S37.
6. Ataş B, Caksen H, Arslan S, Tuncer O, Kirimi E, Odabaş D (2003). PFAPA syndrome mimicking familial Mediterranean fever: report of a Turkish child. J Emerg Med 25 : 383 385.
7. Bandolier (2006). Adverse events with TNF antagonists [July 2006; 149-2]. http://www.jr2.ox.ac.uk/bandolier/band149/b149-2.html [accessed on 17 November 2007].
8. Ben-Chetrit E, Cohen R, Chajek-Shaul T (2002). Familial Mediterranean fever and Behçet's disease - are they associated? J Rheumatol 29 : 530 534.
9. Beutler B, Cerami A (1988). The common mediator of shock, cachexia, and tumor necrosis. Adv Immunol 42 : 213 231.
10. Centola M, Aksentijevich I, Kastner DL (1998). The hereditary periodic fever syndromes: molecular analysis of a new family of inflammatory diseases. Hum Mol Genet 7 : 1581 1588.
11. Church LD, Churchman SM, Hawkins PN, McDermott MF (2006). Hereditary auto-inflammatory disorders and biologics. Springer Semin Immunopathol 27 : 494 508.
12. Compeyrot-Lacassagne S, Rosenberg AM, Babyn P, Laxer RM (2007). Pamidronate treatment of chronic noninfectious inflammatory lesions of the mandible in children. J Rheumatol 34 : 1585 1589.
13. Cortis E, De Benedetti F, Insalaco A et al (2004). Abnormal production of tumor necrosis factor (TNF)-alpha and clinical efficacy of the TNF inhibitor etanercept in a patient with PAPA syndrome. J Pediatr 145 : 851 855.
14. Dahn KA, Glode MP, Chan KH (2000). Periodic fever and pharyngitis in young children: a new disease for the otolaryngologist? Arch Otolaryngol Head Neck Surg 126 : 1146 1149.
15. Deutschmann A, Mache CJ, Bodo K, Zebedin D, Ring E (2005). Successful treatment of chronic recurrent multifocal osteomyelitis with tumor necrosis factor-alpha blockage. Pediatrics 116 : 1231 1233.
16. Dodé C, André M, Bienvenu T et al (2002). The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 46 : 2181 2188.
17. Drenth JP, Haagsma CJ, van der Meer JWM, the International Hyper-IgD Study Group (1994). Hyperimmunoglobulinemia D and periodic fever syndrome: the clinical spectrum in a series of 50 patients. Medicine 73 : 133 144.
18. Drenth JP, van der Meer JW, Kushner I (1996). Unstimulated peripheral blood mononuclear cells from patients with the hyper-IgD syndrome produce cytokines capable of potent induction of C-reactive protein and serum amyloid A in Hep3B cells. J Immunol 157 : 400 404.
19. Drewe E, McDermott EM, Powell PT, Isaacs JD, Powell RJ (2003). Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients. Rheumatology 42 : 235 239. Erratum in: Rheumatology (2003) 42: 711.
20. Drewe E, Huggins ML, Morgan AG, Cassidy MJ, Powell RJ (2004). Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome. Rheumatology 43 : 1405 1408.
21. Espinosa G, Arostegui JI, Plaza S et al (2005). Behçet's disease and hereditary periodic fever syndromes: casual association or causal relationship? Clin Exp Rheumatol 23 (Suppl. 38 S64 S66.
22. Feder HM Jr. (1992). Cimetidine treatment for periodic fever associated with aphthous stomatitis, pharyngitis and cervical adenitis. Pediatr Infect Dis J 11 : 318 321.
23. Feder HM Jr. (2000). Periodic fever, aphthous stomatitis, pharyngitis, adenitis: a clinical review of a new syndrome. Curr Opin Pediatr 12 : 253 256.
24. Frenkel J, Houten SM, Waterham HR et al (2000). Mevalonate kinase deficiency and Dutch type periodic fever. Clin Exp Rheumatol 18 : 525 532.
25. Galeazzi M, Gasbarrini G, Ghirardello A et al (2006). Autoinflammatory syndromes. Clin Exp Rheumatol 24 (Suppl. 40 S79 S85.
26. Galon J, Aksentijevich I, McDermott MF et al (2004). TNFRSF1A mutations and autoinflammatory syndromes. Curr Opin Immunol 4 : 479 486.
27. Girschick HJ, Zimmer C, Klaus G, Darge K, Dick A, Morbach H (2007). Chronic recurrent multifocal osteomyelitis: what is it and how should it be treated? Nat Clin Pract Rheumatol 3 : 733 738.
28. Golla A, Jansson A, Ramser J et al (2002). Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3-18q22. Eur J Hum Genet 10 : 217 221.
29. Grose C, Schnetzer JR, Ferrante A, Vladutiu AO (1996). Children with hyperimmunoglobulinemia D and periodic fever syndrome. Pediatr Infect Dis J 15 : 72 77.
30. Hull KM, Drewe E, Aksentijevich I et al (2002). The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) 81 : 349 368.
31. Imirzalioglu N, Dursun A, Tastan B, Soysal Y, Yakicier MC (2005). MEFV gene is a probable susceptibility gene for Behçet's disease. Scand J Rheumatol 34 : 56 58.
32. Jacobelli S, André M, Alexandra JF, Dodé C, Papo T (2007). Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS). Rheumatology (Oxford) 46 : 1211 1212.
33. Jurik AG (2004). Chronic recurrent multifocal osteomyelitis. Semin Musculoskelet Radiol 8 : 243 253.
34. Kastner DL (2003). The hereditary periodic fevers. In : Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, eds Rheumatology, 3rd edn. Elsevier Limited : Edinburgh, pp. 1717 1734.
35. Koné Paut I, Dubuc M, Sportouch J, Minodier P, Garnier JM, Touitou I (2000). Phenotype-genotype correlation in 91 patients with familial Mediterranean fever reveals a high frequency of cutaneomucous features. Rheumatology (Oxford) 39 : 1275 1279.
36. Lachmann HJ, Sengül B, Yavuzşen TU et al (2006). Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 45 : 746 750.
37. Lavis JF, Gigon S, Gueit I et al (2002). Chronic recurrent multifocal osteomyelitis of the mandible. A case report. Arch Pediatr 9 : 1252 1255.
38. Lindor NM, Arsenault TM, Solomon H, Seidman CE, McEvoy MT (1997). A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc 72 : 611 615.
39. Livneh A, Zaks N, Katz J, Langevitz P, Shemer J, Pras M (1996). Increased prevalence of joint manifestations in patients with recurrent aphthous stomatitis (RAS). Clin Exp Rheumatol 14 : 407 412.
40. Livneh A, Aksentijevich I, Langevitz P et al (2001). A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet's disease (FMF-BD). Eur J Hum Genet 9 : 191 196.
41. Long SS (1999). Syndrome of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) - What it isn't. What is it? J Pediatr 135 : 1 5.
42. Long SS (2005). Distinguishing among prolonged, recurrent, and periodic fever syndromes: approach of a pediatric infectious diseases subspecialist. Pediatr Clin North Am 52 : 811 835.
43. Masson C, Simon V, Hoppé E, Insalaco P, Cissé I, Audran M (2004). Tumor necrosis factor receptor-associated periodic syndrome (TRAPS): definition, semiology, prognosis, pathogenesis, treatment, and place relative to other periodic joint diseases. Joint Bone Spine 71 : 284 290.
44. McDermott MF (1999). Autosomal dominant recurrent fevers. Clinical and genetic aspects. Rev Rhum Engl Ed 66 : 484 491.
45. McDermott MF (2002). Genetic clues to understanding periodic fevers, and possible therapies. Trends Mol Med 8 : 550 554.
46. McDermott MF (2004). A common pathway in periodic fever syndromes. Trends Immunol 25 : 457 460.
47. McDermott MF, Aksentijevich I (2002). The autoinflammatory syndromes. Curr Opin Allergy Clin Immunol 2 : 511 516.
48. McDermott MF, Aksentijevich I, Galon J et al (1999). Germline mutations in the extracellular domains of the 55 kDa TNF receptor,TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97 : 133 144.
49. Medzhitov R, Janeway C Jr. (2000a). Innate immunity. N Engl J Med 343 : 338 344.
50. Medzhitov R, Janeway C Jr. (2000b). Innate immune recognition: mechanisms and pathways. Immunol Rev 173 : 89 97.
51. Nigrovic PA, Sundel RP (2001). Treatment of TRAPS with etanercept: use in pediatrics. Clin Exp Rheumatol 19 : 484 485.
52. Nowlan ML, Drewe E, Bulsara H et al (2006). Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A. Rheumatology (Oxford) 45 : 31 37.
53. Padeh S, Brezniak N, Zemer D et al (1999). Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome. J Pediatr 135 : 98 101.
54. Pinto A, Lindemeyer RG, Sollecito TP (2006). The PFAPA syndrome in oral medicine: differential diagnosis and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 : 35 39.
55. Rabinovich E, Shinar Y, Leiba M, Ehrenfeld M, Langevitz P, Livneh A (2007). Common FMF alleles may predispose to development of Behcet's disease with increased risk for venous thrombosis. Scand J Rheumatol 36 : 48 52.
56. Sarrauste de Menthiere C, Terriere S, Pugnere D, Ruiz M, Demaille J, Touitou I (2003). INFEVERS: the Registry for FMF and hereditary inflammatory disorders mutations. Nucleic Acids Res 31 : 282 285. http://fmf.igh.cnrs.fr/ infevers.
57. Saulsbury FT, Wispelwey B (2005). Tumor necrosis factor receptor-associated periodic syndrome in a young adult who had features of periodic fever, aphthous stomatitis, pharyngitis, and adenitis as a child. J Pediatr 146 : 283 285.
58. Schilling F, Kessler S (2000). SAPHO syndrome: clinico-rheumatologic and radiologic differentiation and classification of a patient sample of 86 cases. Z Rheumatol 59 : 1 28.
59. Schuknecht B, Valavanis A (2003). Osteomyelitis of the mandible. Neuroimaging Clin N Am 13 : 605 618.
60. Scully C, Hodgson TA (2008). Recurrent oral ulcers; there is a trap. Oral Surg Oral Med Oral Pathol Oral Radiol Endod in press.
61. Simon A, Bodar EJ, van der Hilst JC et al (2004). Beneficial response to interleukin 1 receptor antagonist in TRAPS. Am J Med 117 : 208 210.
62. Stichweh DS, Punaro M, Pascual V (2005). Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome. Pediatr Dermatol 22 : 262 265.
63. Stojanov S, Lohse P, Lohse P et al (2004). Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: a low-penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa. Arthritis Rheum 50 : 1951 1958.
64. Tallon B, Corkill M (2006). Peculiarities of PAPA syndrome. Rheumatology (Oxford) 45 : 1140 1143.
65. Tasher D, Somekh E, Dalal I (2006). PFAPA syndrome: new clinical aspects disclosed. Arch Dis Child 91 : 981 984.
66. Thomas KT, Feder HM Jr., Lawton AR, Edwards KM (1999). Periodic fever syndrome in children. J Pediatr 135 : 15 21.
67. Touitou I, Magne X, Molinari N et al (2000). IMEFV mutations in Behçet's disease. Hum Mutat 16 : 271 272.
68. Touitou I, Lesage S, McDermott M et al (2004). Infevers: an evolving mutation database for auto-inflammatory syndromes. Hum Mutat 24 : 194 198.
69. Vilcek J, Lee TH (1991). Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 266 : 7313 7316.
70. Warren JS (1990). Interleukins and tumor necrosis factor in inflammation. Crit Rev Clin Lab Sci 28 : 37 59.
71. Wedman J, van Weissenbruch R (2005). Chronic recurrent multifocal osteomyelitis. Ann Otol Rhinol Laryngol 114 : 65 68.
72. Weihe S, Eufinger H, Terhaar O, König M, Machtens E (2000). Mandibular involvement in chronic recurrent multifocal osteomyelitis (CRMO) in adulthood. Mund Kiefer Gesichtschir 4 : 187 192.
73. Wise CA, Gillum JD, Seidman CE et al (2002). Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 11 : 961 969.